BizeconAnalysis
Fast mobile article powered by Nexiamath-SEO AMP.
AMP Article

Trump administration has quietly throttled an agency devoted to the safety of American healthcare

Published July 31, 2026 · Updated July 31, 2026 · By Linda Hernandez - bizeconanalysis.com

Foto : Linda Hernandez - bizeconanalysis.com

Trump Administration Has Quietly Throttled Healthcare Safety Agency

Bizeconanalysis.com – The Trump administration has quietly throttled the Agency for Healthcare Research and Quality (AHRQ), effectively suspending most of its operations and cutting off federal funding that has saved thousands of lives and billions of dollars over the past 27 years. In a July 15 letter, the Department of Health and Human Services agency informed researchers it was halting at least 104 grants focused on improving patient safety. Despite Congress appropriating $345 million for AHRQ this fiscal year, the agency has spent less than $15 million on grants and hasn't issued a new one in over a year, according to federal records. Approximately 75% of agency staffers have been fired or resigned since President Donald Trump took office.

Widespread Cuts Across Health Research

President Trump and HHS Secretary Robert F. Kennedy Jr. have pursued aggressive reductions in federal biomedical research investment, terminating grants and displacing scientists across the health department. The Trump administration has quietly throttled AHRQ in a move that critics view as particularly shortsighted given the agency's noncontroversial focus on patient safety and its alignment with the "Make American Healthy Again" campaign against chronic illness.

"When you think about everything Americans hate about our health care system — that it costs too much, that you can't get in to see a physician, that the treatment isn't right, that the records contain wrong information — all that is what AHRQ studies," said Aaron Carroll, chief executive of AcademyHealth.

All of AHRQ's grant managers have been fired, meaning there would be no mechanism for the agency to directly oversee future grants, according to Brent Sandmeyer, a former AHRQ program officer. HHS spokesperson Emily Hilliard stated that AHRQ intends to establish a new "framework" for grants, though she did not provide further details when contacted for clarification.

Researchers Express Confusion Over Sudden Cuts

Researchers who received the letter from AHRQ Director Roger Klein expressed bewilderment because much of their work shares the same objectives that Klein highlighted as the agency's current priorities. "AHRQ is the only federal agency that's focused on safety and quality," said Hardeep Singh, director of the Houston Methodist Safety, Quality and Well-Being Institute. His research, funded until recently by AHRQ, has aimed to reduce medical errors introduced by inadequate software design.

Klein stated that AHRQ's research interests include patient safety, preventing antibiotic resistance, countering overmedication of children, promotion of digital health tools, and research "focused on scientifically valid, measurable health outcomes and solution-oriented approaches in health disparities research." KFF Health News examined about 20 of the canceled grants and found that nearly all had objectives that overlapped with the priorities Klein outlined.

"If there's an ideology, lay it out clearly. But there's no clarity whatsoever," said Goutham Rao, chairman of the Department of Family Medicine and Community Health at Case Western Reserve University in Cleveland.

As an AHRQ-funded researcher since 2010, Rao has produced work that led to new approaches for common problems seen in doctors' offices, such as how to respond to weight loss in aged and frail patients. His work has helped reduce diagnostic tests in the elderly and improve hypertension screening of children. "The priorities they lay out in that letter make me think they didn't even look at what we were doing," said Andrea Shields, a University of Connecticut OB-GYN whose AHRQ grant was also eliminated.

A Long Legacy of Patient Safety Innovation

AHRQ-funded research has been instrumental in improving patient safety, structuring medical information technology, and introducing the concept of patient-centered care into the health system. The agency is perhaps best known for its work on curbing hospital infections. Practices introduced because of AHRQ-funded studies prevented an estimated 20,500 deaths and saved $7.7 billion in healthcare costs from 2014 to 2017 alone, according to an analysis the agency conducted.

Teams at Harvard, Yale, and Rand in Santa Monica, California, developed a national standardized patient safety toolkit that has been adopted by hospitals worldwide. The Trump administration has quietly throttled these ongoing efforts at a time when healthcare costs continue to rise and medical errors remain a leading cause of preventable harm.

Frequently Asked Questions

What is AHRQ and why does it matter?

The Agency for Healthcare Research and Quality (AHRQ) is the only federal agency dedicated to improving patient safety and healthcare quality. Its research has saved billions of dollars and thousands of lives through evidence-based practices.

How many grants were affected by the cuts?

AHRQ halted at least 104 grants in July, with nearly all examined grants showing objectives that aligned with the agency's stated priorities under Director Roger Klein.

What happens to AHRQ's future grant program?

With all grant managers fired, AHRQ cannot directly oversee future grants. HHS spokesperson Emily Hilliard indicated a new "framework" will be established, though details remain unclear.

How does this affect patient care?

The cuts threaten ongoing research into medical errors, hospital infections, and patient-centered care—areas that directly impact the quality and safety of healthcare Americans receive daily.

Related Reading